Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world post-marketing study of levamlodipine besylate (Shi Hui Da) in hypertension
ChiCTR2000028731Phase 4Recruiting
- Sponsor
- Fuwai Hospital
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Levamlodipine in hypertension (HTN) (2 arms), sponsored by Fuwai Hospital. Primary endpoint: Blood pressure target achievement rate. Started Apr 2019; status: recruiting.
02
Drugs
Levamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR2000028731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000028731.